Overview

Sub-dissociative Dose Ketamine Dosing Study

Status:
Completed

Trial end date:
2019-09-17

Target enrollment:

Participant gender:

Summary

Goal is to determine if in adults presenting to the Emergency Department (ED) with moderate to severe acute pain, Ketamine administered at 0.15 mg/kg will provide similar pain relief to Ketamine administered at 0.3 mg/kg, with fewer adverse effects.

Phase:

Phase 4

Details

Lead Sponsor:

Loyola University

Treatments:

Ketamine